|
DOSAGE
|
Moderate to severe dry eye syndromes, keratoconjunctivitis sicca, exposure keratitis, decreased corneal sensitivity, recurrent corneal erosion
|
|
INDICATIONS
|
LACRISERT is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with: Exposure keratitis Decreased corneal sensitivity Recurrent corneal erosions
|
|
MECHANISM OF ACTION
|
Cellulose-derivative demulcent
|
|
MICROBIOLOGY
|
LACRISERT acts to stabilize and thicken the precorneal tear film and prolong the tear film breakup time which is usually accelerated in patients with dry eye states. LACRISERT also acts to lubricate and protect the eye.
|
|
CONTRAINDICATIONS & WARNINGS
|
Hypersensitive to hydroxypropyl cellulose
|
|
PEDIATRIC USE
|
Safety and effectiveness in pediatric patients have not been established.
|
|
PREGNANCY
|
Feeding of hydroxypropyl cellulose to rats at levels up to 5% of their diet produced no gross or histopathologic changes or other deleterious effects.
|
